Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal e-CliniC JURNAL BIOMEDIK
Janry A. Pangemanan
University of Sam Ratulangi Manado
Biochemistry, Genetics & Molecular Biology Health Professions

Published : 8 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : JURNAL BIOMEDIK

 1 
THE IMPACT OF METABOLIC SYNDROME ON RADIAL ARTERY DIAMETERS Luntungan, Marshell; Purabaya, Andhi; Budiono, Bambang; Pangemanan, Janry A.; Lefrandt, Reginald L.
Jurnal Biomedik : JBM Vol 5, No 2 (2013): JURNAL BIOMEDIK : JBM
Publisher : UNIVERSITAS SAM RATULANGI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35790/jbm.5.2.2013.2593

Abstract

Abstrak: Dewasa ini akses arteri radialis telah digunakan secara luas pada intervensi koroner transkateter. Pada pasien sindroma metabolik (MetS) yang berisiko tinggi diabetes melitus tipe 2 (DMT2), proses aterosklerosis sistemik telah memengaruhi struktur arteri radialis. Penelitian ini bertujuan untuk menentukan faktor-faktor yang berpengaruh terhadap diameter arteri radialis pada pasien MetS. Penelitian ini bersifat prospektif dan dilaksanakan di Laboratorium Kateterisasi Rumah Sakit Awal Bros Makassar sejak 1 Januari sampai dengan 15 Ferbuari 2013 (45 hari). Hasil penelitian memperlihatkan bahwa dari 40 pasien yang menjalani prosedur angiografi koroner melalui akses transradial, 22 di antaranya (55%) menyandang MetS. Rerata diameter arteri radialis pada kelompok pasien MetS dan non-MetS ialah 2,13 mm dan 2 mm. Lingkar pinggang, lingkar pergelangan, kolesterol total, HDL-C, dan trigliserida berbeda secara bermakna antara kedua kelompok. Analisis statistik dengan regresi linear menunjukkan korelasi bermakna antara diameter arteri radialis terhadap usia saja (r = 0,185;  P < 0,05). Simpulan: Terdapat korelasi bermakna antara diameter arteri radialis dengan usia, dan tidak dengan faktor lainnya. Kata kunci: diameter arteri radialis, sindroma metabolik.     Abstract: Nowadays, radial artery access is widely used as a route for transcatheter coronary interventions. Albeit, in metabolic syndrome (MetS) patients who are at high risks of developing type 2 diabetes mellitus, the systemic atheroslerosis process may have influenced the radial artery structures. This study aimed to determine factors that might influence the radial artery diameters in MetS patients. This was a prospective study conducted in the Catheterization Laboratory Awal Bros Hospital Makassar from 1st January until 15th Febuary 2013 (45 days). The results showed that in this study there were 40 consecutive patients who underwent coronary angiography procedures using the transradial apporach, of these 22 patients (55%) were with MetS. The mean radial artery diameters in MetS and non-MetS patients were 2.13 mm and 2 mm, respectively. The waist circumference, wrist circumference, total cholesterol, HDL-C, and triglyceride were significantly different between the two groups. The data were analyzed by using a  linear regression resulting in radial artery diameters (RAD) which were significantly and positively correlated only with age among  the MetS subjects (r = 0.185, P < 0.05). Conclusion: Among the metabolic syndrome patients radial artery diameters were only significantly correlated to ages, and not other factors. Keywords: radial artery diameter, metabolic syndrome.
PEMANFAATAN SEL PUNCA PADA INFARK MIOKARD Wangko, Loretta C.; Awaloei, J. H.; Pangemanan, Janry A.
Jurnal Biomedik : JBM Vol 3, No 1 (2011): JURNAL BIOMEDIK : JBM
Publisher : UNIVERSITAS SAM RATULANGI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35790/jbm.3.1.2011.854

Abstract

Abstract: World-wide, myocardial infarction and heart failure are still the leading causes of deaths and use up a great deal of money. In myocardial infarction there frequently incur cardiomyocyte injuries. Naturally, resident cardiomyocytes will undergo proliferation and contribute to the increasing and repairing of myocardium post infarction. Unfortunately, this capacity of regeneration is very limited. Moreover, injured cardiomyocytes are replaced by scar tissues. Pharmacotherapy with ACE-Inhibitors and β blockers can give some clinical improvement, but can not inhibit the loss of cardiomyocytes. Nowadays, stem cell therapy has proclaimed some promising benefits. Among all the introduced stem cells, mesenchymal stem cells are the most popular since they have the capability to differentiate and then to develop into cardiomyocytes, maintain the myocardial thickness, reduce heart remodeling of the non infarct myocardium, improve heart function, and can be used from allogenic donors. Besides that, these cells are easier to obtain and isolate, are genetically stable, have the capacity for angiogenesis, homing to the injured areas or inflammation, and supplying growth factors and cytokines for tissue repair. Key words: stem cell, cardiomyocyte, transplantation, donor.     Abstrak: Infark miokard dan gagal jantung masih merupakan penyebab kematian utama di dunia dan menyerap biaya pengobatan yang tinggi. Pada infark miokard sering terjadi cedera kardiomiosit. Secara alamiah kardiomiosit residen akan mengalami proliferasi dan mengambil bagian dalam meningkatkan dan memulihkan miokard pasca infark. Kapasitas regenerasi ini sangat terbatas. Selain itu kardiomiosit yang cedera akan digantikan oleh jaringan ikat. Farmakoterapi dengan penghambat ACE dan β bloker dapat memberikan perbaikan klinis, tetapi tidak dapat menghambat kehilangan kardiomiosit. Dewasa ini terapi sel punca telah mengumandangkan manfaat yang menjanjikan. Dari berbagai sel punca yang dikemukakan, sel punca mesensimal yang paling diminati oleh karena kemampuannya berdiferensiasi dan berkembang menjadi kardiomiosit, mempertahankan ketebalan miokard, menurunkan remodeling jantung pada bagian yang tidak infark, memperbaiki fungsi jantung. dan dapat diambil dari donor alogenik. Disamping itu, sel-sel ini lebih mudah diperoleh dan diisolasi, stabil secara genetik, berkapasitas angiogenesis, homing ke tempat cedera atau inflamasi, dan memasok growth factors dan sitokin untuk perbaikan jaringan. Kata kunci: sel punca, kardiomiosit, transplantasi, donor.
Co-Authors Agnes L. Panda Agus Mawardy, Agus Andhi Purabaya Bambang Budiono Dewi U. Djafar, Dewi U. Dewi Utari Djafar, Dewi Utari Eva Nur Faridah, Eva Nur Ira Posangi J. H. Awaloei Lolaen, Cristina Loretta C. Wangko Marshell Luntungan Polii, Natalia Ch. Reginald L. Lefrandt Sagala, Shendy G.L. Starry H. Rampengan Wagiu, Mutiara B.